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Abstract
Despite remarkable advances in assisted reproductive capabilities ,4% of all couples remain involuntarily infertile. In almost
half of these cases, a lack of conception can in some measure be attributed to the male partner, wherein de novo Y-
chromosomal deletions of sperm-specific Deleted-in-Azoospermia (DAZ) genes are particularly prevalent. In the current
study, long-term cultures of rat spermatogonial stem cells were evaluated after cryo-storage for their potential to restore
fertility to rats deficient in the DAZ-like (DAZL) gene. Detailed histological analysis of DAZL-deficient rat testes revealed an
apparently intact spermatogonial stem cell compartment, but clear failure to produce mature haploid gametes resulting in
infertility. After proliferating .1 million-fold in cell number during culture post-thaw, as few as 50,000 donor spermatogonia
transplanted into only a single testis/recipient effectively restored fecundity to DAZL-deficient rats, yielding 100% germline
transmission to progeny by natural mating. Based on these results, the potency and efficacy of this donor stem cell line for
restoring fertility to azoospermic rodents is currently unprecedented. Prospectively, similar successes in humans could be
directly linked to the feasibility of obtaining enough fully functional spermatogonial stem cells from minimal testis biopsies
to be therapeutically effective. Thus, regeneration of sperm production in this sterile recipient provides an advanced pre-
clinical model for optimizing the efficacy of stem cell therapies to cure a paradoxically increasing number of azoospermic
men. This includes males that are rendered infertile by cancer therapies, specific types of endocrine or developmental
defects, and germline-specific de novo mutations; all of whom may harbor healthy sources of their own spermatogonial
stem cells for treatment.
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Introduction
In total, .5% of the male population is infertile, with male
factors being attributed to nearly 50% of all infertile couples [1,2].
On a global scale, .1% of all males are inflicted with a severe
defect in sperm production termed azoospermia [3,4,5]. Funda-
mentally, because azoospermia results in an inability to reproduce
by natural mating, it seems enigmatic as to why this disease
remains so prevalent in the human population. Such an
epidemiological trend clearly points to the existence of potent
environmental factors that disrupt the process of sperm production
(i.e. spermatogenesis) [4,6], or a substantial repertoire of gene
mutations that could render one sterile, but otherwise healthy
[7,8]. This is in fact true in mammalian species where mutations in
.100 distinct genes have already been shown to disrupt sperm
development or function in mice [7,8]. In humans, ,10% of males
with non-obstructive azoospermia suffer from a ploidy defect
termed Klinefelter Syndrome, where ,1/750 boys are born with a
47, XXY karyotype [9,10]. Additionally, a variety of micro-
deletions from the Y-chromosome are particularly prevalent and
have been linked to ,20% of all cases of male-factor infertility
[3,10,11,12]. A majority these Y-chromosome microdeletions
encompass genes in the DAZ family [12,13].
Rodent genomes do not encode DAZ genes on their Y-
chromosome, but do contain a highly conserved autosome, DAZL,
that is specifically expressed in the germline [14,15]. Like DAZ
genes in humans, DAZL is required for gametogenesis in rodents
[16,17,18]. In mice, DAZL function has been linked to
maintenance of pluripotency [19], epigenetic programming in
the embryonic germline [19], primordial germ cell/gonocyte
survival [18], and is required for oogenesis and spermatogenesis
[16]. In a new transgenic rat model, expression of DAZL was
disrupted by forced expression of a complementary small hairpin
RNA (shRNA) [17]. Interestingly, expression of DAZL in these
‘‘knockdown’’ rats remained sufficient to support fertility in
females [17]. However, as with many men diagnosed with DAZ
gene deletions, DAZL-deficient rats were sterile due to a severe
block in spermatogenesis [17].
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function, another prominent concern resides in the fact that each
year an increasing number of young women and men are left
infertile due to the potent, toxic side-effects of life-saving cancer
therapies on gametogenesis [6,20,21,22]. It is estimated that
,30% of male childhood cancer survivors are inflicted with
azoospermia due to degenerative side effects of chemotherapy on
spermatogenesis [21]. Bilateral cryptorchidism, which is the lack of
testicular descent after birth, is another major cause of
azoospermia in about 1/500 males born [5]. Thus, the best hope
for these boys to someday father their own children currently
depends on the cryopreservation of their spermatogonial stem
cells. Still, this is under anticipation that cellular therapies for
curing spermatogenic arrest are established as a clinical option
early enough in their future.
As a new hope for many such men with azoospermia, a
pioneering breakthrough in reproductive biology was the discov-
ery that spermatogonial stem cells isolated from mouse testes could
maintain their ability to generate fully functional sperm following
transplantation into testes of another mouse [23,24,25]. Similar
experiments soon followed with rats [26], and isolated mouse
spermatogonia were next shown to maintain their regenerative
potential after months in culture [27]. New culture media
supporting the long term proliferation of rodent spermatogonial
lines in vitro have since been formulated [28,29,30,31], and
scientists are now on the brink of establishing conditions required
to cultivate human spermatogonial lines from testis biopsies as a
key step toward using germline stem cells in regenerative medicine
[32,33].
Ostensibly, the ability to propagate human spermatogonial lines
in culture, prior to using them to produce functional spermatozoa
by transplanting them back into the testes of their own donor,
presents a clear strategy to cure many existing types of male
infertility. Establishing these culture methods would overcome the
foreseeable barrier of obtaining enough pure, donor spermatogo-
nia from a minimally invasive testis biopsy to effectively restore a
patient’s fertility. To date, a majority of studies in this area have
been performed in mice [23,25,28,29]. However, due in large part
to the multipotent nature of isolated germline stem cells in culture
[32,33,34,35], and the potential for introducing defective cells
back into patients, it will be informative to evaluate therapeutic
efficacies of spermatogonia in additional pre-clinical mammalian
models, as presented herein, using azoospermic DAZL-deficient
rats [17].
Results
DAZL-Deficient Rats Maintain an Intact Sperm Stem Cell
Compartment
Here, we tested the hypothesis that following cryopreservation,
long term cultures of proliferating spermatogonia could be used to
restore fertility to DAZL-deficient rats [17]. Detailed morphomet-
ric analysis of the spermatogenic defect in DAZL-deficient rats
revealed normal numbers of spermatogonia, but reduced numbers
of spermatocytes and round spermatids in their seminiferous
tubules, culminating in a severe failure to produce elongating
spermatids (Fig. 1A, B). However, based on these analyses, DAZL-
deficient rats appeared to express an intact spermatogonial stem
cell compartment, as evidenced by both undifferentiated and
differentiating populations of spermatogonia within seminiferous
tubules of adult animals (Fig. 1C, D). The presence of a functional
spermatogonial stem cell compartment was verified by in vivo
spermatogenesis colony forming assays in which genetically tagged
donor spermatogonia were thawed from cryo-storage, propagated
over multiple passages in culture, and then transplanted into
seminiferous tubules of busulfan-treated, DAZL-deficient rat testes
(Fig. 2). Donor spermatogonial lines were derived from testes of
individual Germ Cell Specific (GCS)-EGFP transgenic rats [31,36].
GCS-EGFP rats robustly expressed EGFP as a vital marker
specifically during all known steps of gametogenesis [37]. The
DAZL-deficient recipient rat line also expresses EGFP from its
transgene, but at relatively low levels [17]. By comparison, EGFP
is 20-fold more abundant in testes of GCS-EGFP rats than in
DAZL-deficient rats (Fig. 2A). Thus, development of donor
spermatogonia from GCS-EGFP rats was clearly detected following
transplantation into DAZL-deficient rat testes, which they
colonized 3-fold more efficiently than wildtype recipient testes
(Fig. 2B).
Donor Sperm Stem Cells Effectively Restore Fertility to
Dazl-Deficient Rats
The transplanted spermatogonial stem cells effectively devel-
oped into functional spermatozoa, which due to the absence of
sperm competition, transmitted the donor cell haplotype to
progeny .7-fold more efficiently from DAZL-deficient recipients
than from wildtype litter mates (Fig. 3A–C; Table 1). In each
DAZL-deficient recipient, spermatogenesis was regenerated from
the spermatogonial lines that had proliferated in culture (.2
million-fold expansion in cell number) for 5–7 months, yielding
100% germline transmission of the donor haplotype to F1 progeny
by natural mating (Fig. 3A–C; Table 1). The GCS-EGFP transgene
was further transmitted at Mendelian ratios from F1 to F2 progeny
(26% wildtype, 48% heterozygous, 26% homozygous; 81 total
pups; n=6 litters) (Fig. 3D). No evidence of tumor formation was
observed in any of the recipients or progeny. The regenerative
effects of the spermatogonial lines on fertility were also apparent
upon histological examination of testes from DAZL-deficient
recipients at 212 days following transplantation; 5766.1%
(6SE, n=3) of their seminiferous tubules contained colonies of
spermatogenesis that developed to the elongating spermatid stage
(Fig. 4). This represented a .2000-fold increase in the relative
number of elongating spermatids scored/number of Sertoli cells in
transplanted versus non-transplanted DAZL-deficient rat testes
(Fig. 4).
Discussion
Defining molecular mechanisms linked to the enhanced
colonization of donor spermatogonia in DAZL-deficient recipients
will be of potential clinical interest because it could lead to new
therapeutic strategies for optimizing the efficiency at which donor
germ cells engraft testes of infertile men (See Fig. 2B). The ability to
apply such knowledge would theoretically reduce the number of
donor stem cells required to successfully restore a patient’s fertility.
In specific cases, reducing the number of donor stem cells required
per procedure would directly reduce the size of testicular biopsies
needed from the patient. Accordingly, reducing the number of
stems cells needed from a given biopsy would also directly decrease
the relative amount of time for in vitro expansion of a donor
spermatogonial line to obtain enough cells in a pure form to
preserve fertility. In turn, the ability to shorten the time required
for efficient in vitro expansion of donor cells using smaller amounts
of testicular tissue could prove to be critical for cancer survivors
that bank their spermatogonial stem cells prior to therapy.
In addition to colonizing DAZL-deficient rat testes more
efficiently, donor spermatogonial lines transmitted their haplotypes
from DAZL-deficient recipients more efficiently. Depending on the
case at hand, it would also be important to anticipate the relative
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PLoS ONE | www.plosone.org 2 July 2009 | Volume 4 | Issue 7 | e6308Figure 1. Analysis of Spermatogenic Failure in DAZL-Deficient Rats. (A) Relative numbers of spermatogenic cell types/1000 Sertoli cells in
testes of 4 month old wildtype and transgenic DAZL-deficient rats (+/2SEM, n=3 rats/group). Undifferentiated type A spermatogonia (Undif),
differentiating type A spermatogonia (Type A), intermediate to type B spermatogonia (Int-Type B), preleptotene spermatocytes (PL), leptotene-
zygotene spermatocytes (lept-zygo), pachytene-diplotene spermatocytes (Pachy-Di), secondary spermatocytes-round spermatids (SS-RS), elongating
spermatids (ES). Significant differences (i.e. p,0.05) in testis cell types scored in wildtype and DAZL-deficient rats were determined for SS-RS
(p=0.022) and ES (p,0.0001) using unpaired two-tailed students t-test. (B) Histological cross-sections of seminiferous tubules from 4 month old
wildtype (Top left) and transgenic DAZL-deficient rats (Top right). Bottom left and right show higher magnification images of boxed regions in the Top
panels. Scale bars=100 mm. (C) Images of spermatogonial types in testis sections from wildtype rats at stages VIII, XI, XIII, XIV, II and V of
spermatogenesis. Types of undifferentiated (Undif) and differentiating spermatogonia (A1, A2, A3, A4, Int, B) were determined by analysis of staining
patterns in nuclei at specific stages of spermatogenesis. Scale bar=30 mm. (D) Images of spermatogonial types in testis sections from DAZL-deficient
rats. Because stages of the epithelial cycle could not be classified in these rats, types of undifferentiated (Undif) and differentiating spermatogonia
(A1-like, A2-like, A3-like, A4-like, Int-like, B-like) were estimated based on staining profiles of spermatogonia in wildtype rats. Scale bar=30 mm.
doi:10.1371/journal.pone.0006308.g001
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donor and non-transplanted, endogenous germlines in response to
currently unexplored therapeutic factors linked to autologous
transplantation protocols. Biologically, this would apply to
situations in germline mosaics where genetic modifiers uniquely
expressed by donor spermatogonia could potentially rescue the
development of endogenous spermatogonial lines that harbor
undesirable genetic traits. However, in the current model, no
DAZL-deficient progeny were born from transplanted DAZL-
deficient rats (0/155 total F1 pups) exposed to healthy donor
spermatogonia. Thus, neither down-stream effectors of DAZL
produced by the wildtype donor cells, nor other procedural effects
of the transplant were sufficient to stimulate development of
functional spermatozoa from DAZL-deficient rats to levels readily
transmittable by natural breeding. These genetic data support the
hypothesis that germline-specific expression of DAZL is sufficient
to fully rescue male fertility in DAZL-deficient mammals.
Initial studies in monkeys demonstrate the feasibility of the
autologous transplantation approach in primates [38,39,40].
However, more definitive quantitative studies on the ability of
genetically tagged spermatogonial stem cells to colonize, prolifer-
ate and undergo spermatogenic development after autologous
transplantation into non-human primates await [20,22]. More-
over, numbers of functional spermatogonial stem cells that can be
isolated/gram weight of monkey or human tissue have yet to be
clearly estimated. Due to the relative cost and technical demand
Figure 2. DAZL-Deficient Rats are Efficient Spermatogonial Recipients. (A) Relative abundance of EGFP in testes of Wildtype, DAZL-deficient
and GCS-EGFP rats. Left: Data expressed as the equivalents of recombinant, histidine-tagged EGFP (rEGFP)/testis (+/2SEM, n=3 testes/rat strain) as
determined by fluorometry of testis extracts at 24 days of age. Right: Bright field (top) and green fluorescence (bottom) images of testes dissected
from GCS-EGFP, wildtype (WT) and DAZL-deficient (Dazl-Def) rats at 24 days of age. Scale bar=1 cm. (B) Spermatogenesis colony forming assays using
DAZL-deficient rats as recipients. Left: Numbers of spermatogenic colonies formed/testis by donor GCS-EGFP rat spermatogonia in Wildtype (10.25+/
20.68 colonies/testis, +/2SEM, n=8 testes) and DAZL-Deficient rats (30.69+/20.62 colonies/testes, +/2SEM, n=8 testes) at 30 days following
transplantation; p,0.0001, unpaired two-tailed students t-test. Donor spermatogonia were transplanted at passages 15 and 17 (i.e. culture days 182
and 204) at 2000 GCS-EGFP
+ cells/testis. Right: Images of individual colonies of spermatogenesis in Wildtype and DAZL-deficient recipient rats that
were generated by the donor GCS-EGFP spermatogonia (green fluorescence is from donor cells). Images are representative of colonies scored and
plotted in the Left panel. Scale bar=100 mm.
doi:10.1371/journal.pone.0006308.g002
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PLoS ONE | www.plosone.org 4 July 2009 | Volume 4 | Issue 7 | e6308Figure 3. Maximal Donor Germline Transmission from DAZL-Deficient Rats. (A) Southern blot analysis of progeny from Wildtype (WT) and
DAZL-Deficient (Dazl) recipient rats transplanted with 50,000 GCS-EGFP spermatogonia/right testis at passage 13 (i.e. 158 days in culture); left testes of
each animal were not transplanted. At 75 days post-transplantation recipients (R) were paired with WT females (F) and allowed to produce pups by
natural breeding (See R942-R949 in Table 1). Shown are blots from representative litters probed for EGFP to distinguish progeny produced by donor
cells. OMP=loading control. Genomic DNA Controls were from untreated GCS-EGFP and DAZL-Deficient transgenic rats. LTR=PCR primers specific for
lentiviral transgene in DAZL-deficient rats. GAPDH=PCR loading control. (B) Bright field and green fluorescence images of testes from Wildtype (Left)
and DAZL-deficient (Right) recipient rats at 212 days post-transplantation. Scale bar=1 cm. (C) Graph of germline transmission rates for the donor,
GCS-EGFP transgene from Wildtype and DAZL-deficient recipient rats transplanted with 50,000 GCS-EGFP spermatogonia/right testis at passage 13;
left testes were not transplanted. DAZL-deficient recipients transmitted the GCS-EGFP transgene to 100%+/20% of progeny (+/2SEM, n=3 recipients;
9 litters), with 73 of 73 total F1 pups born from donor cells. Wildtype recipients transmitted the GCS-EGFP transgene to 14%+/25.9% of progeny
(+/2SEM, n=3 recipients; 9 litters), with 16 of 116 total F1 pups born from donor cells. (D) Genealogy tree showing stable transmission of donor
haplotypes from DAZL-Deficient recipients (F0) R989 and R990 to F1 and F2 progeny. Recipients were each transplanted with 150,000 rat
spermatogonia/testis from line RSGL-GCS9 at passage 17 (See R988-R990 in Table 1). Spermatogonial line RSGL-GCS9 was derived from a rat
homozygous for the GCS-EGFP transgene [36]. Thus, F1 progeny represent half-siblings; some of which were crossed to re-derive transgenic F2
progeny homozygous for the tgGCS-EGFP allele.
doi:10.1371/journal.pone.0006308.g003
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primates, studies aimed at defining molecular mechanisms with
potential to help optimize the efficacy of donor spermatogonia are
being applied primarily in rodent models [41]. For example,
progressive studies in rat and mouse models for cancer therapy
have established that colonization and development of donor
spermatogonia in irradiated testes can be enhanced by pharma-
cological suppression of testosterone [41,42], and that transplan-
tation of Sertoli cells can stimulate development of spermatogonia
in rat testes damaged by irradiation [43]. These experimental
designs in rodents could now be translated to non-human primates
[20,22].
Currently, many infertile men are unable to produce sperma-
tozoa (i.e. azoospermia), or have low sperm counts (i.e.
oligospermia) due to de novo deletion of one to four members in
the DAZ gene family from the human Y-chromosome [12,13].
Variants of these microdeletions account for ,18% of men with
non-obstructive azoospermia or severe oligospermia [44]. Rodent
genomes do not have DAZ genes on their Y-chromosome, but do
express a single homologue of human DAZL from chromosome 17
specifically in the germline [14]. Consistent with the phenotype in
DAZL-deficient rats, spermatogenesis defects in DAZL-deficient
mice mirror many forms of male-factor infertility caused by Y-
chromosome microdeletions of human DAZ genes. Like in humans
[12], the severity of spermatogenic failure in these mutant rodents
ranges widely from a Sertoli-cell-only phenotype [18] to pre-
meiotic [45] and meiotic [17,46] stages of spermatogenic arrest;
these phenotypes highlight the potential impact of yet to be
defined genetic modifiers on spermatogenesis. Moreover, a recent
report by Haston, et al., provides new insight into the potential
etiology of these defects by showing that DAZL is required to
maintain proper epigenetic and genetic programs at multiple
stages during gametogenesis [19].
Given extraordinary advances in regenerative medicine,
together with the advent of spermatogonial culture
[27,28,31,36], clinical application of stem cells to cure specific
types of infertility now appears more promising than ever (Fig. 5).
Once optimized for specific curable cases of azoospermia, the
ability to regenerate spermatogenesis using proliferating cultures of
human spermatogonial stem cells holds remarkable potential to
not only help battle infertility as a disease, but as a condition that
can have profound, detrimental psychological effects on the
quality of people’s lives whom cannot parent their own children
[47]. Defining molecular mechanisms that contribute to the
enhanced efficacy of donor spermatogonia in DAZL-deficient rats
could open new doors to advance this endeavor.
Materials and Methods
Animal Care and Use
Protocols for the use of rats in this study were approved by the
Institutional Animal Care and Use Committee (IACUC) at UT-
Southwestern Medical Center in Dallas. Rats used for this study
werehousedinindividuallyventilated,LabProducts2100cagesina
dedicated room with atmosphere controls set to 72uF, 45–50%
humidity during a 12 hour light/dark cycle (i.e. Light cy-
cle=6:00am-6:00pm, Central Standard Time adjusted for daylight
savings time). Rats were fed Harlan Teklad Irradiated 7912, LM-
485 Mouse/Rat Diet, 5% fat Diet and a continuous supply of
reverse osmosis water.
Table 1. Progeny from Wildtype and DAZL-Deficient Recipient Rats Transplanted with GCS-EGFP Rat Spermatogonia.
Recipient
Recipient
Background
Culture
Passage
Number
Days to
Analysis
Gram wt per R,
L testis Cells per R, L testis
Days to
first
litter
1
Number
Litters
Average
Litter Size
Total Pups
Born
Pups Born from
Transplanted
Stem Cells
2 (%)
3
Group 1
R946 Wildtype p13 212 0.569, 0.341 50,000:0 127 3 11.3 34 3 (8.8)
R948 Wildtype p13 212 0.735, 0.278 50,000:0 131 3 10 30 11 (36.7)
R949 Wildtype p13 212 1.054, 0.201 50,000:0 113 3 17.3 52 2 (3.8)
Average p13 212 0.786, 0.273 50,000:0 123.7 3 12.9 38.7 4.3 (16.4)
Group 2
R942 DAZL-Def p13 212 0.572, 0.286 50,000:0 154 3 8.7 26 26 (100)
R943 DAZL-Def p13 212 0.651, 0.377 50,000:0 141 3 7.7 23 23 (100)
R944 DAZL-Def p13 212 0.511, 0.326 50,000:0 156 3 8 24 24 (100)
Average p13 212 0.578, 0.330 50,000:0 150 3 8.1 24.3 24.3 (100)
Group 3
R988 DAZL-Def p17 236 0.523, 0.578 150,000:150,000 122 3 12.7 38 38 (100)
R989 DAZL-Def p17 236 0.489, 0.439 150,000:150,000 128 3 9.3 28 28 (100)
R990 DAZL-Def p17 236 0.487, 0.371 150,000:150,000 136 3 5.3 16 16 (100)
Average p17 236 0.499, 0.427 150,000:150,000 128.6 3 9.1 27.3 27.3 (100)
Wildtype or DAZL-deficient (DAZL-def) recipient rats were transplanted with either 0.5 or 1.5610
5 EGFP
+ cells/testis from rat spermatogonial line GCS9 at 12 days after
busulfan treatment (i.e. 12 mg/kg i.p.) on postnatal day 24. At ,75 days post-transplantation recipients were paired with 75–80 day old wildtype female rats.
Spermatogonia line GCS9 was harvested from passages number 13 and 17, which corresponded to 158 and 204 days in culture, respectively, prior to their
transplantation. Recipients R942-R949 were littermates born from a hemizygous, transgenic DAZL-deficient female and a wildtype Sprague Dawley male. No progeny
were born from breeder pairs of un-transplanted, busulfan-treated DAZL-deficient males and wild-type females (n=3 breeder pairs). Breeder pairs of untreated, wild-
type male litter mates of DAZL-deficient rats and wild-type female rats from Harlan, Inc. produced 15.564.5 pups/litter (+/2SEM, n=8 litters from 3 breeder pairs).
1p=0.0209 Average Group 1 versus Average Group 2; p=0.0251 Average Group 2 versus Average Group 3.
2p=0.0031 Average Group 1 versus Average Group 2.
3Percent GCS-EGFP
+ F1 progeny.
doi:10.1371/journal.pone.0006308.t001
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Seminiferous tubules were isolated from testes of 23–24 day old
homozygous SD-Tg(ROSA-EGFP)2-4Reh Sprague Dawley rats.
Rats of the SD-Tg(ROSA-EGFP)2-4Reh line were produced by
pronuclear injection, exhibit germ cell-specific expression of
enhanced green fluorescent protein (EGFP) throughout male
and female gametogenesis, and are referred to as GCS-EGFP rats
[37]. For deriving each spermatogonial line, seminiferous tubules
were isolated from an individual rat and then enzymatically and
mechanically dissociated into a cellular suspension to generate a
testis cell culture [48]. The testis cell culture was then used to
isolate enriched populations of laminin-binding germ cells, which
are highly enriched in spermatogonial stem cells [48]. The
laminin-binding fraction of germ cells was then used to derive
proliferating cultures of spermatogonia [i.e. rat spermatogonial
lines RSGL-GCS9 and RSGL-GCS10] in Spermatogonial
Culture Medium (SG Medium) [36]. Passage 11, RSGL-GCS9
was thawed after 396 days of cryo-storage at 2196uCi nS G
Medium containing 10% DMSO (i.e. Spermatogonial Freezing
Medium), and then sub-cultured in fresh SG Medium, as
previously described [36], for use in experiments between passage
13–17.
Germ Cell Transplantation and Colonization
The DAZL-deficient rat line was produced on a Sprague Dawley
background and expresses a small hairpin RNA (shRNA)
transgene designed to stimulate degradation of transcripts
encoding DAZL [17]. Rats in the DAZL-deficient transgenic line
are male-sterile due to a defect in spermatogenesis; however,
female rats from the same line remained fully fertile [17]. To
prepare recipients for transplantation of spermatogonia, hetero-
zygous DAZL-deficient male rats or their wildtype litter mates were
injected (i.p.) with 12 mg/kg busulfan (4 mg/ml in 50% DMSO)
at 12 days of age. Busulfan is an alkylating agent cytotoxic to
spermatogonia used to increase the effectiveness of spermatogonial
transplantations [31,40], and clinically to combat cancer in
humans [6,22]. At 24 days of age (i.e. 12 days after busulfan
treatment) donor tgGCS-EGFP rat spermatogonia harvested from
culture at either passage 13 (culture day 158) or passage 17 (culture
day 204) were loaded into injection needles fashioned from 100 ml
glass capillary tubes at concentrations ranging from 2610
3 to
1.5610
5 EGFP
+ cells/50 ml culture media containing 0.04%
trypan blue. The entire 50 ml volume was then transferred into the
seminiferous tubules of anesthetized rats by retrograde injection
through the rete of their right testes [48]. The number of EGFP
+
colonies formed/testis were scored using an Olympus IX70
fluorescence microscope (Olympus, Inc) to visualize donor cell
transgene expression in the seminiferous tubules at 30 days
following transplantation. Images of recipient testis were taken
with a Nikon SMZ1500 fluorescence stereomicroscope.
Morphometric Analysis of Rat Spermatogenic Cells
HistologicalAnalysisofRatTestes: Spermatogenesis was evaluated in
hematoxylin and eosin (H&E) stained, 3 mm thick histological
sections prepared from testes of wild-type and DAZL-deficient
littermates at 4 months of age, and from DAZL-deficient recipients
at 212 days post-transplantation with spermatogonia (i.e. ,8
months of age). Prior to sectioning, the right testis of each animal
Figure 4. Long-Term Spermatogenic Potential of Donor Spermatogonia. (Left) Graph showing relative numbers of Round and Elongating
Spermatids in seminiferous tubules of non-transplanted, non-busulfan-treated, Wildtype and DAZL-deficient rat lines at 4 months of age (see Fig. 1a),
in comparison to Spermatid numbers in busulfan-treated, DAZL-deficient recipient rats at 212 days (i.e. ,8 months of age) after being transplanted
with rat spermatogonial line, RSGL-GCS9, at passage 13 (i.e. culture day 158). Cell counts were normalized/1000 Sertoli cells. +/2SEM, n=3 rats/
group. (Right) Images of histological sections of seminiferous tubules from the DAZL-deficient recipient rats described in the ‘‘Left’’ panel after being
transplanted with spermatogonia from RSGL-GCS9. Bottom Right shows a higher magnification image within the boxed region of the Top Right panel.
Scale bars=100 mm.
doi:10.1371/journal.pone.0006308.g004
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washed thoroughly in 70% ethanol and then embedded in
paraffin. The average numbers of Sertoli cells, gonocytes, type-A
spermatogonia (Type-A), intermediate to type-B spermatogonia
(Type-B), pre-leptotene spermatocytes (PL), leptotene to early
pachytene spermatocytes (L-EP), mid-pachytene to diplotene
spermatocytes (MP-D), round spermatids (RS) and elongating
spermatids (ES) were scored/tubular cross section. Sections were
prepared from triplicate animals for each genotype. Numbers of
cells per tubular cross-section were counted for each of the above
categories by morphometric analysis using the Simple PCI
software (Simple-PCI, Inc.) in line with an AX70 light microscope
(Olympus, Inc). Cells in cross sections of each rat were counted in
microscopic fields of 15,400 mm
2 (140 mm6110 mm) from at least
30 tubules/rat, n=3 rats/strain. Average counts for each cell type
were normalized per 1000 Sertoli cells from triplicate rats of each
group. Spermatogenic cell types in wild-type rats were classified
based on their morphologies in the H&E-stained sections and
localization to specific stages of a seminiferous epithelial cycle [49].
The spermatogenic stage of each tubule used to count spermato-
gonia and Sertoli cells was verified in parallel cross-sections (3 mm)
stained by the periodic acid-Schiff method in order to visualize
steps of rat spermiogenesis. In DAZL-deficient rats, spermatogonia
were classified as either undifferentiated (Undif) or differentiated
(Dif) based on their patterns of H&E staining in comparison to
wild-type rats. This was due to the inability to clearly identify
distinct spermatogenic stages in the DAZL-deficient rats.
Histological Analysis of Spermatogonial Types
In wild-type rats, the numbers of undifferentiated and
differentiating spermatogonia per tubular cross section were first
scored at stages VIII, XI, XIII, XIV, II and V of spermatogenesis
to avoid scoring differentiating spermatogonia in M-phase.
Undifferentiated spermatogonia were clearly distinguished from
differentiating types during each stage due to their relative lack of
nuclear staining. As bright field images, undifferentiated sper-
matogonia were lightly stained throughout the cytoplasm and
nucleus, and appeared ‘‘pinkish’’ compared to differentiating types
of spermatogonia. Between stages V and VII, nucleoli of Aal
spermatogonia became more prominent as they differentiated into
type A1 spermatogonia. In contrast, types A1 to B spermatogonia
showed increasingly darker staining in distinct regions of their
chromatin as they differentiated. Types A1 and A2 spermatogonia
often showed ‘‘spots’’ of darkly stained chromatin situated
randomly in the nucleus, which sharply contrasted from lighter
staining chromatin throughout the rest of the nucleus. Nuclei of
types A1 and A2 spermatogonia were clearly distinct from nuclei
of undifferentiated spermatogonia. Types A3 to B spermatogonia
also showed dark patterns of chromatin staining with increasing
peri-nuclear localization of the most intensely stained regions.
Figure 5. Prospective Procedures for Curing Azoospermia with Stem Cells. In many cases of spermatogenic failure, healthy sources of
spermatogonia could be obtained from either a biopsy of an azoospermic patient’s own testis, or prospectively, from a biopsy of his own somatic
cells following induction into a pluripotent state. Pure spermatogonial lines derived from either source would require that they are maintained in a
spermatogenic lineage and prevented from acquiring a pluripotent state when in culture. If such protocols were established, naturally healthy
spermatogonial lines could be selected for from a background of potentially unhealthy cell lines, such as from cancer patients, or azoospermic men
diagnosed as germline mosaics (later example is shown). Once selected for, the healthy lines could then be induced to develop into sperm by
transplanting them back into the patient’s own testes. As potential alternatives to sterile-testis complementation that are currently being
investigated, spermatogonial stem cells could be induced to develop through meiosis during culture in vitro, or within tissue grafts for production of
haploid gametes [50]. The resulting haploid spermatids could then be used for assisted fertilization.
doi:10.1371/journal.pone.0006308.g005
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Seminiferous tubules of recipient animals were dissected from
the testes of 24 day old rats and then homogenized in 1.5 ml of
ice-cold lysis buffer [50 mM HEPES pH 8.0, 150 mM NaCl,
1 mM EDTA, 10% glycerol, 1% TritonX-100, 10 mg/ml
aprotinin, 10 mg/ml leupeptin and 1 protease inhibitor tablet/
12.5 ml] for 30 seconds using a PTA-7 probe on setting 5 of a
PT10-35 polytron (Kinematica). The homogenates were incubated
on ice for 15–20 min and then centrifuged at 3000 x g for 10 min
at 4uC in a GPR table-top centrifuge (Beckman, Inc.). The
supernatant solutions were centrifuged at 15,800 x g for 10 min at
4uC in a micro-centrifuge (Model 5042, Eppendorf, Inc.), and the
resultant supernatant fractions were then stored at 280uC. Frozen
supernatant solutions were thawed on ice and then further
clarified by centrifugation at 230,000 x g,r av (tla-100.3 rotor,
TL1000 ultracentrifuge, Beckman, Inc.) for 30 min at 4uC.
Standards and supernatant solutions from the final centrifugation
step were diluted into assay buffer [100 mM sodium bicarbonate,
pH 9.6] and then analyzed for fluorescent intensity using a FL600
fluorescence micro-titer plate reader (BioTek, Inc.) equipped with
filter wheel sets for maximal excitation at 485 nm and maximal
emission at 516 nm. Affinity purified recombinant EGFP with a
carboxyl-terminal histidine tag (rEGFP-His) was used as a
standard for determining equivalents of EGFP in lysates prepared
from testes of recipient animals. The rEGFP-His was produced by
transient expression from the vector pcDNA6.0-EGFP-V5-His-B
following transfection (Fugene 6 transfection reagent, Roche, Inc.)
into COS-7 cells as previously described [48].
Genotyping Progeny from Recipient Rats
Transgenic rat progeny from crosses between wild-type
recipients and wild-type females were genotyped by PCR analysis
of genomic DNA using primers specific to the EGFP transgene,
and the LTR region of the lentiviral transgene used to produce the
DAZL-deficient rat line; primers to GAPDH were used to amplify
loading controls. Transgene copy number in F2 progeny from
hemizygous crosses between F1 progeny of recipients and wildtype
females was determined by qtPCR using primers to EGFP and the
18S ribosomal subunit. Genotyping results were verified by
Southern blot hybridization assays of genomic DNA digested
with Xmn1 and Xba1 using a probe specific for the EGFP
transgenes, and for olfactory marker protein as a loading control.
The EGFP probe was isolated as a Nhe1/EcoR1 fragment from
pLEGFP-C1 (Clonetech, Inc.). The OMP probe was isolated as a
BamH1 fragment from pTOPO-XL:OMP corresponding to base
pairs 14268243-14269267 of NW_047561; GI:34857865; RGSC
v3.4 [31]. EGFP PCR primers: 59-GTCTCGTGACCCTGACC-
TACGG-39 and 59-ATGCCCTTCAGCTCGATGCGG-39; Rat
GAPDH PCR primers: 59-ATGATTCTACCCACGGCAAG-39
and 59-GCTAAGCAGTTGGTGGTGCA-39; Lentiviral trans-
gene PCR primers to LTR region: 59-AACAGGGACTT-
GAAAGCG-39 and 59-ATACTGACGCTCTCGCACCC-39.
Genotyping results were also confirmed in representative progeny
by direct visualization of EGFP transgene expression in testes and
ovaries using a Nikon SMZ1500 fluorescence stereomicroscope.
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